Earnings

Earnings Articles

Twitter, Inc. (NYSE: TWTR) is scheduled to release its fourth-quarter earnings report before the markets open on Thursday. After a great deal of ups and downs, which have been mostly downs,...
Over the past 52 weeks, organic grocer Whole Foods Market has suffered through earnings reports, corporate restructuring and falling comps and margins.
24/7 Wall St. has included some highlights from the Gilead Sciences earnings report, as well as what analysts are saying afterward.
24/7 Wall St. has put together a preview of Coca-Cola, CVS Health and some of the other most anticipated quarterly earnings reports that are due on Thursday.
24/7 Wall St. has put together a preview of some of the larger companies in the tech and media sectors reporting their quarterly results on Thursday.
Twilio reported better-than-expected fourth-quarter financial results after the markets closed on Tuesday.
Time Warner reports better-than-expected fourth-quarter and full-year numbers on strong movie revenues, but it has little to say about its impending merger.
Disney revenues lag, with weakness at ESPN and in the movie business.
Gilead Sciences Inc. (NASDAQ: GILD) reported its fourth-quarter earnings after the markets closed on Tuesday. The company posted $2.70 in earnings per share (EPS) and $7.3 billion in revenue,...
Sabre Corp. (NASDAQ: SABR) saw itself as one of the biggest earnings losers on Tuesday after the company came out with its most recent report and hit a new 52-week low. However, a closer look at the...
There are a lot of things going in Disney’s favor, including the beloved Star Wars franchise. One analyst has named Disney as one of its top picks for 2017.
Gilead Sciences is set to report its fourth-quarter financial results after the markets close on Tuesday.
GM reported record full-year and fourth-quarter revenues as the company posted global retail sales of more than 10 million vehicles.
Michael Kors reported mixed fiscal third-quarter financial results before the markets opened on Tuesday.
GW Pharmaceuticals, a developer of therapeutics derived from marijuana, reported a smaller than expected loss in its 2017 first quarter.